Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3171 | 2047 | 38.9 | 78% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
171 | 3 | MONASCUS//CITRININ//MONASCUS PURPUREUS | 58457 |
43 | 2 | JOURNAL OF LIPID RESEARCH//HDL//LIPOPROTEINS | 30963 |
3171 | 1 | APOLIPOPROTEIN E//LIPOPROTEIN GLOMERULOPATHY//TYPE III HYPERLIPOPROTEINEMIA | 2047 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | APOLIPOPROTEIN E | authKW | 1130614 | 25% | 15% | 502 |
2 | LIPOPROTEIN GLOMERULOPATHY | authKW | 686106 | 2% | 100% | 46 |
3 | TYPE III HYPERLIPOPROTEINEMIA | authKW | 531397 | 2% | 76% | 47 |
4 | APOLIPOPROTEIN E POLYMORPHISM | authKW | 504103 | 3% | 65% | 52 |
5 | APOE POLYMORPHISM | authKW | 325581 | 2% | 53% | 41 |
6 | FAMILIAL DYSBETALIPOPROTEINEMIA | authKW | 213065 | 1% | 71% | 20 |
7 | DYSBETALIPOPROTEINEMIA | authKW | 186427 | 1% | 63% | 20 |
8 | APOLIPOPROTEIN E PHENOTYPE | authKW | 158349 | 1% | 56% | 19 |
9 | APOE | authKW | 109648 | 5% | 7% | 100 |
10 | TYPE III HYPERLIPIDEMIA | authKW | 93213 | 0% | 63% | 10 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Peripheral Vascular Diseases | 3680 | 13% | 0% | 266 |
2 | Medical Laboratory Technology | 3271 | 7% | 0% | 140 |
3 | Genetics & Heredity | 1575 | 13% | 0% | 260 |
4 | Cardiac & Cardiovascular System | 1484 | 12% | 0% | 239 |
5 | Biochemistry & Molecular Biology | 1130 | 23% | 0% | 470 |
6 | Endocrinology & Metabolism | 695 | 8% | 0% | 169 |
7 | Medicine, Research & Experimental | 569 | 7% | 0% | 150 |
8 | Nutrition & Dietetics | 516 | 5% | 0% | 98 |
9 | Medicine, General & Internal | 457 | 9% | 0% | 174 |
10 | Urology & Nephrology | 386 | 5% | 0% | 97 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | LIPID BIOL HLTH DIS GRP | 43136 | 0% | 32% | 9 |
2 | GENOM SING ORE | 29831 | 0% | 100% | 2 |
3 | POLICLIN MED INTERNA | 29831 | 0% | 100% | 2 |
4 | UNIDADE QUIM CLIN | 29831 | 0% | 100% | 2 |
5 | CENT S HOSP | 19886 | 0% | 67% | 2 |
6 | MOINHO DE VENTO HOSP | 19886 | 0% | 67% | 2 |
7 | GLADSTONE CARDIOVASC DIS | 16125 | 1% | 5% | 23 |
8 | ATHEROSCLEROSIS GENET | 15728 | 1% | 7% | 15 |
9 | MEDICAMENT | 15214 | 0% | 15% | 7 |
10 | A CYB SCI RADIOL | 14915 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ATHEROSCLEROSIS | 19797 | 6% | 1% | 119 |
2 | JOURNAL OF LIPID RESEARCH | 18486 | 5% | 1% | 103 |
3 | ARTERIOSCLEROSIS AND THROMBOSIS | 7089 | 1% | 2% | 20 |
4 | HUMAN BIOLOGY | 7089 | 1% | 2% | 30 |
5 | METABOLISM-CLINICAL AND EXPERIMENTAL | 4482 | 3% | 1% | 52 |
6 | LIPIDS IN HEALTH AND DISEASE | 3917 | 1% | 1% | 20 |
7 | ARTERIOSCLEROSIS | 3490 | 1% | 2% | 13 |
8 | CLINICAL GENETICS | 2949 | 2% | 1% | 32 |
9 | ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2254 | 2% | 0% | 34 |
10 | CLINICAL CHEMISTRY | 1673 | 2% | 0% | 37 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | APOLIPOPROTEIN E | 1130614 | 25% | 15% | 502 | Search APOLIPOPROTEIN+E | Search APOLIPOPROTEIN+E |
2 | LIPOPROTEIN GLOMERULOPATHY | 686106 | 2% | 100% | 46 | Search LIPOPROTEIN+GLOMERULOPATHY | Search LIPOPROTEIN+GLOMERULOPATHY |
3 | TYPE III HYPERLIPOPROTEINEMIA | 531397 | 2% | 76% | 47 | Search TYPE+III+HYPERLIPOPROTEINEMIA | Search TYPE+III+HYPERLIPOPROTEINEMIA |
4 | APOLIPOPROTEIN E POLYMORPHISM | 504103 | 3% | 65% | 52 | Search APOLIPOPROTEIN+E+POLYMORPHISM | Search APOLIPOPROTEIN+E+POLYMORPHISM |
5 | APOE POLYMORPHISM | 325581 | 2% | 53% | 41 | Search APOE+POLYMORPHISM | Search APOE+POLYMORPHISM |
6 | FAMILIAL DYSBETALIPOPROTEINEMIA | 213065 | 1% | 71% | 20 | Search FAMILIAL+DYSBETALIPOPROTEINEMIA | Search FAMILIAL+DYSBETALIPOPROTEINEMIA |
7 | DYSBETALIPOPROTEINEMIA | 186427 | 1% | 63% | 20 | Search DYSBETALIPOPROTEINEMIA | Search DYSBETALIPOPROTEINEMIA |
8 | APOLIPOPROTEIN E PHENOTYPE | 158349 | 1% | 56% | 19 | Search APOLIPOPROTEIN+E+PHENOTYPE | Search APOLIPOPROTEIN+E+PHENOTYPE |
9 | APOE | 109648 | 5% | 7% | 100 | Search APOE | Search APOE |
10 | TYPE III HYPERLIPIDEMIA | 93213 | 0% | 63% | 10 | Search TYPE+III+HYPERLIPIDEMIA | Search TYPE+III+HYPERLIPIDEMIA |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SINGH, PP , SINGH, M , MASTANA, SS , (2006) APOE DISTRIBUTION IN WORLD POPULATIONS WITH NEW DATA FROM INDIA AND THE UK.ANNALS OF HUMAN BIOLOGY. VOL. 33. ISSUE 3. P. 279 -308 | 131 | 66% | 101 |
2 | BENNET, AM , DI ANGELANTONIO, E , YE, Z , WENSLEY, F , DAHLIN, A , AHLBOM, A , KEAVNEY, B , COLLINS, R , WIMAN, B , DE FAIRE, U , ET AL (2007) ASSOCIATION OF APOLIPOPROTEIN E GENOTYPES WITH LIPID LEVELS AND CORONARY RISK.JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. VOL. 298. ISSUE 11. P. 1300-1311 | 82 | 67% | 339 |
3 | DEKNIJFF, P , VANDENMAAGDENBERG, AMJM , FRANTS, RR , HAVEKES, LM , (1994) GENETIC-HETEROGENEITY OF APOLIPOPROTEIN-E AND ITS INFLUENCE ON PLASMA-LIPID AND LIPOPROTEIN LEVELS.HUMAN MUTATION. VOL. 4. ISSUE 3. P. 178-194 | 130 | 75% | 110 |
4 | DAVIGNON, J , GREGG, RE , SING, CF , (1988) APOLIPOPROTEIN-E POLYMORPHISM AND ATHEROSCLEROSIS.ARTERIOSCLEROSIS. VOL. 8. ISSUE 1. P. 1-21 | 77 | 71% | 1585 |
5 | FRIKKE-SCHMIDT, R , (2000) CONTEXT-DEPENDENT AND INVARIANT ASSOCIATIONS BETWEEN APOE GENOTYPE AND LEVELS OF LIPOPROTEINS AND RISK OF ISCHEMIC HEART DISEASE: A REVIEW.SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION. VOL. 60. ISSUE . P. 3 -25 | 95 | 82% | 11 |
6 | SONG, YQ , STAMPFER, MJ , LIU, SM , (2004) META-ANALYSIS: APOLIPOPROTEIN E GENOTYPES AND RISK FOR CORONARY HEART DISEASE.ANNALS OF INTERNAL MEDICINE. VOL. 141. ISSUE 2. P. 137-147 | 66 | 74% | 303 |
7 | MARAIS, AD , SOLOMON, GAE , BLOM, DJ , (2014) DYSBETALIPOPROTEINAEMIA: A MIXED HYPERLIPIDAEMIA OF REMNANT LIPOPROTEINS DUE TO MUTATIONS IN APOLIPOPROTEIN E.CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES. VOL. 51. ISSUE 1. P. 46-62 | 73 | 66% | 12 |
8 | VAN GIAU, V , BAGYINSZKY, E , AN, SSA , KIM, S , (2015) ROLE OF APOLIPOPROTEIN E IN NEURODEGENERATIVE DISEASES.NEUROPSYCHIATRIC DISEASE AND TREATMENT. VOL. 11. ISSUE . P. 1723 -1737 | 86 | 50% | 1 |
9 | WEISGRABER, KH , (1994) APOLIPOPROTEIN-E - STRUCTURE-FUNCTION-RELATIONSHIPS.ADVANCES IN PROTEIN CHEMISTRY, VOL 45. VOL. 45. ISSUE . P. 249-302 | 82 | 57% | 564 |
10 | KOLOVOU, G , DAMASKOS, D , ANAGNOSTOPOULOU, K , COKKINOS, DV , (2009) APOLIPOPROTEIN E GENE POLYMORPHISM AND GENDER.ANNALS OF CLINICAL AND LABORATORY SCIENCE. VOL. 39. ISSUE 2. P. 120-133 | 73 | 65% | 21 |
Classes with closest relation at Level 1 |